$MOS

MOSAIC CO

0
0
2
$509K
Precourt Walter F. III
0%
See all $MOS insider activity →
Med

Mosaic (MOS) Bets On Enzymes While Its Core Business Bleeds

Mosaic Biosciences, a unit of The Mosaic Company (MOS), launched Renuvis Enzara, an enzyme-based treatment for crop residue. MOS reported a Q2 net loss of $273M, reversing from a $411M profit in 2025. The company cut its 2026 capex outlook to $1.2B and sold a potash mine. Phosphate segment losses widened, while Potash remained stable. Shares trade at a forward P/E of 15.92.

Farmers Push Trump To Wage All-Out War Against Big Fertilizer

U.S. farmers are urging the Trump administration to use antitrust laws against major fertilizer companies, including Mosaic, Nutrien, CF Industries, Koch Agronomic Services, and Yara International. The DOJ is already investigating these firms for potential price-fixing.

Rainbow, Mosaic begin pre-feasibility study for Brazil project

Rainbow Rare Earths (RBW) and Mosaic (MOS) started a Pre-Feasibility Study for the Uberaba rare earths project in Brazil. SRK Consulting will prepare a JORC-compliant Mineral Resource Estimate. Mosaic will ship 6 tonnes of phosphogypsum for testing. The study aims to build a processing plant for 2.7M tonnes/year of phosphogypsum waste, producing rare earth oxides. An Economic Assessment in March showed a post-tax NPV10 of $916M, IRR of 45%, and average EBITDA of $217M/year over 30 years.

MOS sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning MOS (MOSAIC CO). Coverage has skewed bearish: 0 bullish, 0 neutral, and 2 bearish.

Recent MOS coverage spans corporate actions, regulation and financial news.

In the last 30 days, MOS insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($509K). The most active reporter was Precourt Walter F. III, SVP - Chief Admin Officer, with 1 filing.

What's driving MOS

AlphAI scores every news story that mentions MOS with an AI model for sentiment and relevance, and aggregates insider trades from MOSAIC CO's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $MOS

Score
$MOSMedAI 8/10

Mosaic (MOS) Bets On Enzymes While Its Core Business Bleeds

Mosaic Biosciences, a unit of The Mosaic Company (MOS), launched Renuvis Enzara, an enzyme-based treatment for crop residue. MOS reported a Q2 net loss of $273M, reversing from a $411M profit in 2025. The company cut its 2026 capex outlook to $1.2B and sold a potash mine. Phosphate segment losses widened, while Potash remained stable. Shares trade at a forward P/E of 15.92.

Rainbow, Mosaic begin pre-feasibility study for Brazil project

Rainbow Rare Earths (RBW) and Mosaic (MOS) started a Pre-Feasibility Study for the Uberaba rare earths project in Brazil. SRK Consulting will prepare a JORC-compliant Mineral Resource Estimate. Mosaic will ship 6 tonnes of phosphogypsum for testing. The study aims to build a processing plant for 2.7M tonnes/year of phosphogypsum waste, producing rare earth oxides. An Economic Assessment in March showed a post-tax NPV10 of $916M, IRR of 45%, and average EBITDA of $217M/year over 30 years.

Mosaic (MOS) Redeems Debt As Its Undervalued Narrative Comes Into Focus

Mosaic (MOS) redeemed $537M in debt using cash on hand, improving its risk profile. Its share price rose 9.04% in the past month and 3.52% in the past quarter, but fell 25.25% over the past year. The company's fair value is estimated at $26.82, suggesting it is undervalued. Favorable fertilizer market dynamics may lift revenue and margins, but risks include reliance on commodity pricing and higher costs.

$NTRLow

Fertilizer concentration concerns Iowa Corn leadership

The U.S. Department of Justice is investigating leading fertilizer producers, including Nutrien, Mosaic, CF Industries, Koch, and Yara, for potential antitrust violations. Iowa Corn Growers Association President Mark Mueller cites industry consolidation and high prices as concerns. Farmers argue that fewer suppliers have not led to promised cost savings. The investigation is in early stages, with no accusations made. Farmers seek greater transparency in pricing.

$MOSMed

MOSAIC CO (MOS): Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

MOSAIC CO (MOS) filed an SEC Form 8-K — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth under Item 8.01 below is incorporated by reference into this Item 2.03. Item 8.01. Other Events. On August 17, 2026, The Mosaic

Related tickers